Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?

Intellia Therapeutics (NASDAQ: NTLA) and CRISPR Therapeutics (NASDAQ: CRSP) are pioneers in developing CRISPR gene-editing therapies. In this Motley Fool Live video recorded on Nov. 10, 2021, Motley Fool contributors Keith Speights and Brian Orelli address a viewer's question about a potentially major safety risk that both of these companies face.

Continue reading

Source Fool.com